Experimental Treatment Pushed By ALS Patients Gets Day Before FDA, But Agency Unconvinced It Works
The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a
Source: theyeshivaworld.com